David Armstrong
David Armstrong
Farncombe Institute, McMaster University
Verified email at mcmaster.ca - Homepage
TitleCited byYear
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
LR Lundell, J Dent, JR Bennett, AL Blum, D Armstrong, JP Galmiche, ...
Gut 45 (2), 172-180, 1999
The endoscopic assessment of esophagitis: a progress report on observer agreement
Gastroenterology 111 (1), 85-92, 1996
The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria
P Sharma, J Dent, D Armstrong, JJ Bergman, L Gossner, Y Hoshihara, ...
Gastroenterology 131 (5), 1392-1399, 2006
Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial
P Moayyedi, MG Surette, PT Kim, J Libertucci, M Wolfe, C Onischi, ...
Gastroenterology 149 (1), 102-109. e6, 2015
Consumption of fluid skim milk promotes greater muscle protein accretion after resistance exercise than does consumption of an isonitrogenous and isoenergetic soy-protein beverage
SB Wilkinson, MA Tarnopolsky, MJ MacDonald, JR MacDonald, ...
The American journal of clinical nutrition 85 (4), 1031-1040, 2007
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved …
A Barkun, S Sabbah, R Enns, D Armstrong, J Gregor, RNN Fedorak, ...
The American journal of gastroenterology 99 (7), 1238, 2004
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment–Prompt …
ABR Thomson, AN Barkun, D Armstrong, N Chiba, RJ White, S Daniels, ...
Alimentary pharmacology & therapeutics 17 (12), 1481-1491, 2003
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process
C Bennett, N Vakil, J Bergman, R Harrison, R Odze, M Vieth, S Sanders, ...
Gastroenterology 143 (2), 336-346, 2012
Between celiac disease and irritable bowel syndrome: the “no man's land” of gluten sensitivity
EF Verdu, D Armstrong, JA Murray
The American journal of gastroenterology 104 (6), 1587, 2009
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults–update 2004
D Armstrong, JK Marshall, N Chiba, R Enns, R Fass, R Hollingworth, ...
Can J Gastroenterol 19 (1), 15, 2005
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.
EF Verdu, D Armstrong, R Fraser, F Viani, JP Idström, CH Cederberg, ...
Gut 36 (4), 539-543, 1995
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori.
SJO Veldhuyzen van Zanten, N Flook, N Chiba, D Armstrong, A Barkun, ...
CMAJ: Canadian Medical Association Journal 162, 2000
Helicobacter pylori infection and dyspepsia
D Armstrong
Scandinavian Journal of Gastroenterology 31 (sup215), 38-47, 1996
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
J Dent, D Armstrong, B Delaney, P Moayyedi, NJ Talley, N Vakil
Gut 53 (suppl 4), iv1-iv24, 2004
EUS: a meta-analysis of test performance in suspected choledocholithiasis
F Tse, L Liu, AN Barkun, D Armstrong, P Moayyedi
Gastrointestinal endoscopy 67 (2), 235-244, 2008
Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes
AM Schoepfer, C Beglinger, A Straumann, E Safroneeva, Y Romero, ...
Inflammatory bowel diseases 19 (2), 332-341, 2013
Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?
V Stanghellini, D Armstrong, H Mönnikes, KD Bardhan
Digestion 75 (Suppl. 1), 3-16, 2007
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study
J Labenz, D Armstrong, K Lauritsen, P Katelaris, S Schmidt, K Schütze, ...
Alimentary pharmacology & therapeutics 21 (6), 739-746, 2005
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.
EF Verdu, D Armstrong, JP Idström, J Labenz, M Stolte, G Dorta, G Börsch, ...
Gut 37 (6), 743-748, 1995
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on …
NJ Talley, TL Venables, JRB Green, D Armstrong, KPJ O'Kane, M Giaffer, ...
European journal of gastroenterology & hepatology 14 (8), 857-863, 2002
The system can't perform the operation now. Try again later.
Articles 1–20